Retraction notice to “Astragaloside IV remodels gastric inflammation-cancer transformation by modulating the CXCL5-CXCR2 axis-mediated epithelial-mesenchymal transition” [Phytomedicine 155 (2026) 158081]
Phytomedicine
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Cite
Get new articles on “Drug Discovery”
Subscriptions, keyword tracking and favourites — in the Articlium Telegram bot.
Open in Telegram
Citation
✕
ГОСТ
APA
MLA
BibTeX
Retraction notice to “Astragaloside IV remodels gastric inflammation-cancer transformation by modulating the CXCL5-CXCR2 axis-mediated epithelial-mesenchymal transition” [Phytomedicine 155 (2026) 158081]. // Phytomedicine. – URL: https://www.sciencedirect.com/science/article/pii/S0944711326010949?dgcid=rss_sd_all
Retraction notice to “Astragaloside IV remodels gastric inflammation-cancer transformation by modulating the CXCL5-CXCR2 axis-mediated epithelial-mesenchymal transition” [Phytomedicine 155 (2026) 158081]. Phytomedicine. https://www.sciencedirect.com/science/article/pii/S0944711326010949?dgcid=rss_sd_all
“Retraction notice to “Astragaloside IV remodels gastric inflammation-cancer transformation by modulating the CXCL5-CXCR2 axis-mediated epithelial-mesenchymal transition” [Phytomedicine 155 (2026) 158081].” Phytomedicine.
@article{article62367,
title = {Retraction notice to “Astragaloside IV remodels gastric inflammation-cancer transformation by modulating the CXCL5-CXCR2 axis-mediated epithelial-mesenchymal transition” [Phytomedicine 155 (2026) 158081]},
journal = {Phytomedicine},
url = {https://www.sciencedirect.com/science/article/pii/S0944711326010949?dgcid=rss_sd_all}
}